Discover 532 paid clinical trials in Louisville, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 532
Active & Responsive
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
for
Multiple Myeloma
Location: Louisville KY, Indianapolis IN, Cleveland OH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT04133636
Phase2, Recruiting
Active & Responsive
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
for
Obesity
Location: Louisville KY, Bristol TN, City of Saint Peters MO,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT06780449
Phase3, Recruiting
Active & Responsive
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
for
Cardiovascular Diseases, Metabolic Health
Location: Louisville KY
Sponsor: University of Louisville
Sex: All
Age: 30 - 70
Code: NCT03670524
Recruiting
Active & Responsive
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Louisville KY, Nashville TN, Chicago IL, Cleveland OH,
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Louisville KY, Greenville SC, Decatur GA, Atlanta GA,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase2, Recruiting
Active & Responsive
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies